XML 99 R40.htm IDEA: XBRL DOCUMENT v3.20.1
Note 1 - Organization and Basis of Presentation (Details Textual)
3 Months Ended 12 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
shares
Apr. 11, 2019
USD ($)
$ / shares
shares
Mar. 20, 2019
USD ($)
$ / shares
shares
Feb. 13, 2018
shares
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
Conversion of Stock, Shares Issued       0.22148      
Stock Issued During Period, Shares, Reverse Stock Splits       7,100,000      
Exchange Ratio, Number of Shares Exchanged Per Share       0.0201346      
Stock Issued During Period, Shares, New Issues     1,200,000        
Gross Proceeds from Issuance of Common Stock | $     $ 3,000,000        
Proceeds from Issuance of Common Stock | $     2,500,000     $ 2,540,000
Payments of Stock Issuance Costs | $     $ 320,000        
Proceeds from Warrant Exercises | $           $ 180,000
Class of Warrant or Right, Outstanding         43,370,162 43,370,162  
Payments for Aggregate Commissions to Underwriters | $   $ 750,000          
The April 2019 Offering [Member]              
Stock Issued During Period, Shares, New Issues, Excluding Shares Sold to Underwriters   925,455          
Shares Issued, Price Per Share | $ / shares   $ 1.10          
Proceeds from Issuance or Sale of Equity, Total | $   $ 9,300,000          
Net Proceeds from Issuance of Common Stock, Pre-funded Warrants and Common Warrants in Underwritten Offering | $   $ 8,100,000       $ 8,074,000
The September 2019 Offering [Member]              
Stock Issued During Period, Shares, New Issues, Excluding Shares Sold to Underwriters 26,124,828            
Shares Issued, Price Per Share | $ / shares $ 0.30            
Pre-funded Warrant Price | $ / shares 0.20            
Pre-funded Warrant, Accompanying Warrant, Amount Paid Per Share | $ / shares $ 0.10            
Proceeds from Issuance or Sale of Equity, Total | $ $ 8,700,000            
Net Proceeds from Issuance of Common Stock, Pre-funded Warrants and Common Warrants in Underwritten Offering | $ 7,700,000         7,739,000
Payments for Aggregate Commissions to Underwriters | $ $ 713,000            
Warrants in Connection with March 2019 Offering [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     84,000        
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right     1        
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 3.125        
Warrants and Rights Outstanding, Term     5 years        
Warrants and Rights Outstanding | $     $ 100,000        
Warrants in Connection With the April 2019 Offering [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   10,454,546          
Warrants and Rights Outstanding | $   $ 333,000          
Class of Warrant Right, Number of Pre-funded Warrants Issued During Period   8,165,455          
Pre-funded Warrant Price | $ / shares   $ 1          
Pre-funded Warrant, Accompanying Warrant, Amount Paid Per Share | $ / shares   $ 0.10          
Proceeds from Warrant Exercises | $           $ 800,000  
Warrants in Connection With the April 2019 Offering [Member] | Over-Allotment Option [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   1,363,636          
Pre-funded Warrants [Member]              
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 1 1          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 0.10 $ 0.10          
Class of Warrant Right, Number of Pre-funded Warrants Issued During Period 4,100,000            
Proceeds from Warrant Exercises | $         $ 400,000    
Class of Warrant or Right, Outstanding         8,165,455 8,165,455  
Class of Warrant or Right, Exercised During Period         4,100,000    
Common Warrants [Member]              
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 1 1          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 0.30 $ 1.10          
Warrants and Rights Outstanding, Term 5 years 5 years          
Class of Warrant or Right, Exercised During Period         598,067    
Underwriter Warrants [Member]              
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right   1          
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares   $ 1.375          
Class of Warrant or Right, Issued During Period   636,364          
Class of Warrant or Right, Period to Expiration   5 years          
Class of Warrant or Right, Issued During Period, Fair Value | $   $ 333,000          
Warrants in Connection with the September 2019 Offering [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 30,666,667            
Warrants and Rights Outstanding | $ $ 497,000            
Class of Warrant or Right, Exercised During Period 3,558,161            
Warrants in Connection with the September 2019 Offering [Member] | Over-Allotment Option [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 4,000,000            
Common Stock Warrants [Member]              
Proceeds from Warrant Exercises | $         $ 200,000    
Underwriter Warrants, September 2019 [Member]              
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 1            
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 0.375            
Warrants and Rights Outstanding | $ $ 497,000            
Class of Warrant or Right, Issued During Period 2,115,738            
Class of Warrant or Right, Period to Expiration 5 years            
Private Vaxart's Stockholders, Warrantholders, and Optionholders [Member]              
Ownership Percentage       51.00%      
Aviragens Stockholderrs and Optionholders [Member]              
Ownership Percentage       49.00%      
Reverse Stock Split [Member]              
Stockholders' Equity Note, Stock Split, Conversion Ratio       11